Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience

Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience

Linked article: This article is commented on by M. Scalvenzi et al., pp. e146–e147 in this issue. To view this article visit https://doi.org/10.1111/jdv.15469.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the European Academy of Dermatology and Venereology 2019-04, Vol.33 (4), p.e144-e145
Hauptverfasser: Woltsche, N., Pichler, N., Wolf, I., Di Meo, N., Zalaudek, I.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e145
container_issue 4
container_start_page e144
container_title Journal of the European Academy of Dermatology and Venereology
container_volume 33
creator Woltsche, N.
Pichler, N.
Wolf, I.
Di Meo, N.
Zalaudek, I.
description Linked article: This article is commented on by M. Scalvenzi et al., pp. e146–e147 in this issue. To view this article visit https://doi.org/10.1111/jdv.15469.
doi_str_mv 10.1111/jdv.15367
format Article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1111_jdv_15367</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JDV15367</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2927-62f72b7259aa0e7e0e0848099e9d88e20879ddabb90ddc760db34448948897b83</originalsourceid><addsrcrecordid>eNp1kE1P3DAQhq0KVBbaQ_8AmiuHgPOxsd1bRVugAnGhvUb-mCRGib2yvUv3V_EX8XahN-Ywo5GeeUZ6CflS0vMy18Wj2ZyXy7plH8iibFpe1JTXB2RBRdUWQizFETmO8ZFSWpZL_pEc1bRhFRP1gjzfSScH6waQZoMhImDfo04R1BaMz3tAs9bJegdmHXZg8OtkHUIKKNOMLoHvYfJaTtN2Z5FOowElo5xA45SbDNo6P0t4smmENCKMaAYc_QDWjVbZ5ANsbJy9wcGqryAh5k8T5nuX3wD-XWGwmMWfyGEvp4ifX-cJ-f3zx8PldXF7f3Vz-e220JWoWNFWPasUq5ZCSooMKVLecCoECsM5VpQzYYxUSlBjNGupUXXTNFw0nAumeH1CzvZeHXyMAftuFewsw7YrabcLvcuhd_9Cz-zpnl2t1YzmP_mWcgYu9sCTnXD7vqn79f3PXvkC6s-QFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience</title><source>Access via Wiley Online Library</source><creator>Woltsche, N. ; Pichler, N. ; Wolf, I. ; Di Meo, N. ; Zalaudek, I.</creator><creatorcontrib>Woltsche, N. ; Pichler, N. ; Wolf, I. ; Di Meo, N. ; Zalaudek, I.</creatorcontrib><description>Linked article: This article is commented on by M. Scalvenzi et al., pp. e146–e147 in this issue. To view this article visit https://doi.org/10.1111/jdv.15469.</description><identifier>ISSN: 0926-9959</identifier><identifier>EISSN: 1468-3083</identifier><identifier>DOI: 10.1111/jdv.15367</identifier><identifier>PMID: 30472793</identifier><language>eng</language><publisher>England</publisher><ispartof>Journal of the European Academy of Dermatology and Venereology, 2019-04, Vol.33 (4), p.e144-e145</ispartof><rights>2018 European Academy of Dermatology and Venereology</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2927-62f72b7259aa0e7e0e0848099e9d88e20879ddabb90ddc760db34448948897b83</citedby><cites>FETCH-LOGICAL-c2927-62f72b7259aa0e7e0e0848099e9d88e20879ddabb90ddc760db34448948897b83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjdv.15367$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjdv.15367$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30472793$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Woltsche, N.</creatorcontrib><creatorcontrib>Pichler, N.</creatorcontrib><creatorcontrib>Wolf, I.</creatorcontrib><creatorcontrib>Di Meo, N.</creatorcontrib><creatorcontrib>Zalaudek, I.</creatorcontrib><title>Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience</title><title>Journal of the European Academy of Dermatology and Venereology</title><addtitle>J Eur Acad Dermatol Venereol</addtitle><description>Linked article: This article is commented on by M. Scalvenzi et al., pp. e146–e147 in this issue. To view this article visit https://doi.org/10.1111/jdv.15469.</description><issn>0926-9959</issn><issn>1468-3083</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><recordid>eNp1kE1P3DAQhq0KVBbaQ_8AmiuHgPOxsd1bRVugAnGhvUb-mCRGib2yvUv3V_EX8XahN-Ywo5GeeUZ6CflS0vMy18Wj2ZyXy7plH8iibFpe1JTXB2RBRdUWQizFETmO8ZFSWpZL_pEc1bRhFRP1gjzfSScH6waQZoMhImDfo04R1BaMz3tAs9bJegdmHXZg8OtkHUIKKNOMLoHvYfJaTtN2Z5FOowElo5xA45SbDNo6P0t4smmENCKMaAYc_QDWjVbZ5ANsbJy9wcGqryAh5k8T5nuX3wD-XWGwmMWfyGEvp4ifX-cJ-f3zx8PldXF7f3Vz-e220JWoWNFWPasUq5ZCSooMKVLecCoECsM5VpQzYYxUSlBjNGupUXXTNFw0nAumeH1CzvZeHXyMAftuFewsw7YrabcLvcuhd_9Cz-zpnl2t1YzmP_mWcgYu9sCTnXD7vqn79f3PXvkC6s-QFA</recordid><startdate>201904</startdate><enddate>201904</enddate><creator>Woltsche, N.</creator><creator>Pichler, N.</creator><creator>Wolf, I.</creator><creator>Di Meo, N.</creator><creator>Zalaudek, I.</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>201904</creationdate><title>Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience</title><author>Woltsche, N. ; Pichler, N. ; Wolf, I. ; Di Meo, N. ; Zalaudek, I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2927-62f72b7259aa0e7e0e0848099e9d88e20879ddabb90ddc760db34448948897b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Woltsche, N.</creatorcontrib><creatorcontrib>Pichler, N.</creatorcontrib><creatorcontrib>Wolf, I.</creatorcontrib><creatorcontrib>Di Meo, N.</creatorcontrib><creatorcontrib>Zalaudek, I.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Woltsche, N.</au><au>Pichler, N.</au><au>Wolf, I.</au><au>Di Meo, N.</au><au>Zalaudek, I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience</atitle><jtitle>Journal of the European Academy of Dermatology and Venereology</jtitle><addtitle>J Eur Acad Dermatol Venereol</addtitle><date>2019-04</date><risdate>2019</risdate><volume>33</volume><issue>4</issue><spage>e144</spage><epage>e145</epage><pages>e144-e145</pages><issn>0926-9959</issn><eissn>1468-3083</eissn><abstract>Linked article: This article is commented on by M. Scalvenzi et al., pp. e146–e147 in this issue. To view this article visit https://doi.org/10.1111/jdv.15469.</abstract><cop>England</cop><pmid>30472793</pmid><doi>10.1111/jdv.15367</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0926-9959
ispartof Journal of the European Academy of Dermatology and Venereology, 2019-04, Vol.33 (4), p.e144-e145
issn 0926-9959
1468-3083
language eng
recordid cdi_crossref_primary_10_1111_jdv_15367
source Access via Wiley Online Library
title Managing adverse effects by dose reduction during routine treatment of locally advanced basal cell carcinoma with the hedgehog inhibitor vismodegib: a single centre experience
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T05%3A06%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Managing%20adverse%20effects%20by%20dose%20reduction%20during%20routine%20treatment%20of%20locally%20advanced%20basal%20cell%20carcinoma%20with%20the%20hedgehog%20inhibitor%20vismodegib:%20a%20single%20centre%20experience&rft.jtitle=Journal%20of%20the%20European%20Academy%20of%20Dermatology%20and%20Venereology&rft.au=Woltsche,%20N.&rft.date=2019-04&rft.volume=33&rft.issue=4&rft.spage=e144&rft.epage=e145&rft.pages=e144-e145&rft.issn=0926-9959&rft.eissn=1468-3083&rft_id=info:doi/10.1111/jdv.15367&rft_dat=%3Cwiley_cross%3EJDV15367%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/30472793&rfr_iscdi=true